337 related articles for article (PubMed ID: 22244051)
1. Two decades of experience with the Haemophilus influenzae serotype b conjugate vaccine in the United Kingdom.
Ladhani SN
Clin Ther; 2012 Feb; 34(2):385-99. PubMed ID: 22244051
[TBL] [Abstract][Full Text] [Related]
2. Fall in Haemophilus influenzae serotype b (Hib) disease following implementation of a booster campaign.
Ladhani S; Slack MP; Heys M; White J; Ramsay ME
Arch Dis Child; 2008 Aug; 93(8):665-9. PubMed ID: 17942585
[TBL] [Abstract][Full Text] [Related]
3. Antibody concentration and clinical protection after Hib conjugate vaccination in the United Kingdom.
Heath PT; Booy R; Azzopardi HJ; Slack MP; Bowen-Morris J; Griffiths H; Ramsay ME; Deeks JJ; Moxon ER
JAMA; 2000 Nov; 284(18):2334-40. PubMed ID: 11066183
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity of a fourth dose of Haemophilus influenzae type b (Hib) conjugate vaccine and antibody persistence in young children from the United Kingdom who were primed with acellular or whole-cell pertussis component-containing Hib combinations in infancy.
Southern J; McVernon J; Gelb D; Andrews N; Morris R; Crowley-Luke A; Goldblatt D; Miller E
Clin Vaccine Immunol; 2007 Oct; 14(10):1328-33. PubMed ID: 17699835
[TBL] [Abstract][Full Text] [Related]
5. Haemophilus influenzae type b (Hib) seroprevalence and current epidemiology in England and Wales.
Collins S; Litt D; Almond R; Findlow J; Linley E; Ramsay M; Borrow R; Ladhani S
J Infect; 2018 Apr; 76(4):335-341. PubMed ID: 29289561
[TBL] [Abstract][Full Text] [Related]
6. Haemophilus influenzae type b immunization in infants in the United Kingdom: effects of diphtheria/tetanus/acellular pertussis/Hib combination vaccine, significant prematurity, and a fourth dose.
Berrington JE; Cant AJ; Matthews JN; O'Keeffe M; Spickett GP; Fenton AC
Pediatrics; 2006 Apr; 117(4):e717-24. PubMed ID: 16549502
[TBL] [Abstract][Full Text] [Related]
7. Haemophilus influenzae serotype b conjugate vaccine failure in twelve countries with established national childhood immunization programmes.
Ladhani S; Heath PT; Slack MP; McIntyre PB; Diez-Domingo J; Campos J; Dagan R; Ramsay ME;
Clin Microbiol Infect; 2010 Jul; 16(7):948-54. PubMed ID: 19889054
[TBL] [Abstract][Full Text] [Related]
8. Haemophilus influenzae type b disease among children in rural Mozambique: impact of vaccine introduction.
Sigaúque B; Vubil D; Sozinho A; Quintó L; Morais L; Sacoor C; Carvalho MG; Verani JR; Alonso PL; Roca A
J Pediatr; 2013 Jul; 163(1 Suppl):S19-24. PubMed ID: 23773589
[TBL] [Abstract][Full Text] [Related]
9. Vaccine failures after primary immunisation with Haemophilus influenzae type-b conjugate vaccine without booster.
Booy R; Heath PT; Slack MP; Begg N; Moxon ER
Lancet; 1997 Apr; 349(9060):1197-202. PubMed ID: 9130940
[TBL] [Abstract][Full Text] [Related]
10. Combined Haemophilus Influenzae type B-Neisseria meningitidis serogroup C vaccine is immunogenic and well tolerated in preterm infants when coadministered with other routinely recommended vaccines.
Omeñaca F; Arístegui J; Tejedor JC; Moreno-Perez D; Ruiz-Contreras J; Merino JM; Muro Brussi M; Sánchez-Tamayo T; Castro Fernandez J; Cabanillas L; Peddiraju K; Mesaros N; Miller JM
Pediatr Infect Dis J; 2011 Nov; 30(11):e216-24. PubMed ID: 21747321
[TBL] [Abstract][Full Text] [Related]
11. Primary and booster immunization with a diphtheria, tetanus, acellular pertussis, hepatitis B (DTPa-HBV) and Haemophilus influenzae type b (Hib) vaccine administered separately or together is safe and immunogenic.
Marshall H; McIntyre P; Roberton D; Dinan L; Hardt K
Int J Infect Dis; 2010 Jan; 14(1):e41-9. PubMed ID: 19467896
[TBL] [Abstract][Full Text] [Related]
12. Long-term immunological follow-up of children with haemophilus influenzae serotype b vaccine failure in the United Kingdom.
Ladhani S; Heath PT; Ramsay ME; Slack MP; Kibwana E; Pollard AJ; Booy R
Clin Infect Dis; 2009 Aug; 49(3):372-80. PubMed ID: 19580418
[TBL] [Abstract][Full Text] [Related]
13. A nationwide population-based surveillance of invasive Haemophilus influenzae diseases in children after the introduction of the Haemophilus influenzae type b vaccine in Japan.
Suga S; Ishiwada N; Sasaki Y; Akeda H; Nishi J; Okada K; Fujieda M; Oda M; Asada K; Nakano T; Saitoh A; Hosoya M; Togashi T; Matsuoka M; Kimura K; Shibayama K
Vaccine; 2018 Sep; 36(38):5678-5684. PubMed ID: 30122645
[TBL] [Abstract][Full Text] [Related]
14. Haemophilus influenzae Type B conjugate vaccine introduction in Mali: impact on disease burden and serologic correlate of protection.
Sow SO; Tapia MD; Diallo S; Keita MM; Sylla M; Onwuchekwa U; Pasetti MF; Kotloff KL; Levine MM
Am J Trop Med Hyg; 2009 Jun; 80(6):1033-8. PubMed ID: 19478272
[TBL] [Abstract][Full Text] [Related]
15. The UK Hib vaccine experience.
Heath PT; McVernon J
Arch Dis Child; 2002 Jun; 86(6):396-9. PubMed ID: 12023165
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of Haemophilus influenzae type b Conjugate vaccine introduction into routine childhood immunization in Kenya.
Cowgill KD; Ndiritu M; Nyiro J; Slack MP; Chiphatsi S; Ismail A; Kamau T; Mwangi I; English M; Newton CR; Feikin DR; Scott JA
JAMA; 2006 Aug; 296(6):671-8. PubMed ID: 16896110
[TBL] [Abstract][Full Text] [Related]
17. Changing epidemiology of invasive Haemophilus influenzae in Ontario, Canada: evidence for herd effects and strain replacement due to Hib vaccination.
Adam HJ; Richardson SE; Jamieson FB; Rawte P; Low DE; Fisman DN
Vaccine; 2010 May; 28(24):4073-8. PubMed ID: 20398617
[TBL] [Abstract][Full Text] [Related]
18. Spotlight on DTPa-HBV-IPV/Hib Vaccine (Infanrix hexa).
Dhillon S
BioDrugs; 2010 Oct; 24(5):299-302. PubMed ID: 20795752
[TBL] [Abstract][Full Text] [Related]
19. Invasive Haemophilus influenzae type b disease in England and Wales: who is at risk after 2 decades of routine childhood vaccination?
Collins S; Ramsay M; Campbell H; Slack MP; Ladhani SN
Clin Infect Dis; 2013 Dec; 57(12):1715-21. PubMed ID: 24076970
[TBL] [Abstract][Full Text] [Related]
20. Evaluation and validation of a serum bactericidal antibody assay for Haemophilus influenzae type b and the threshold of protection.
Townsend K; Ladhani SN; Findlow H; Borrow R
Vaccine; 2014 Sep; 32(43):5650-6. PubMed ID: 25138290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
